Immunohistochemical staining confirmed the enhancement of T491 phosphorylation, MEK activity, and Ki67 expression in the tumors of these two groups, and these elevations were detected in cancer cells but not in stromal cells (Figure 5E). This evidence concerns the gene MAP2K7 and cancer.